Answers are grounded in this paper and cite their sources.
Dear Editor,Treatment of pemphigus vulgaris (PV) patients, as a chronic bullous disease, with immunosuppressive agents could affect the course of COVID-19 (1). Nowadays, rituximab, an anti-CD20 mon...
No takes yet. Share an insight, caveat, or question.
Shahidi‐Dadras et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: